CAPR 8-K: SEC filing
Capricor Therapeutics
Filed with the SEC on · accession 0001104659-26-125150
CAPR filed a 8-K (current report) with the SEC on Nov 10, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -9.9% by the first close after the filing.
Summary of the filing
Capricor Therapeutics issued a press release announcing its financial results for the quarter ended September 30, 2026, and provided a corporate update.
Key details
How CAPR stock reacted
Close before
$9.85
Nov 9, 2026
First close after
-9.95%
$8.87
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for CAPR, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CAPR?
Click hereFrequently asked questions
What did CAPR file with the SEC on Nov 10, 2026?
CAPR filed a 8-K (SEC filing). Capricor Therapeutics issued a press release announcing its financial results for the quarter ended September 30, 2026, and provided a corporate update.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did CAPR stock react to this filing?
CAPR closed at $9.85 before the filing and $8.87 on Nov 10, 2026 (-9.95%).
Other CAPR SEC filings
- 10-Q · SEC filingNov 10, 2026
- SCHEDULE 13G/A · SEC filingOct 14, 2026
- SCHEDULE 13G · SEC filingSep 14, 2026
- 8-K · SEC filingAug 24, 2026
- SCHEDULE 13G · SEC filingAug 19, 2026
- 10-Q · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 8-K · SEC filingAug 13, 2026
- 8-K · Fda rejectionJul 30, 2026
- 8-K · Fda approvalJul 29, 2026
Get alerts when CAPR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days